Mymetics Corp (MYMX)

[Phosphene]

Agree with you Castaways.

Why wouldn't this proactively be pushed to forefront for fast track

or at least reviewed weeks ago?

World leaders and pharmaceutical industry would be wise to at least

consider the MACIVIVA Horizon 2020 findings.

Effective, needle-free route with levels of immune response

comparative to that obtained by subcutaneous injection.

Distribution wouldn't be problematic and it's a cost efficient

method that could reach the masses.

Lack of transparency remains.

Later.